Trademark: 79233966
Word
SVANQEL
Status
Dead
Status Code
402
Status Date
Tuesday, January 4, 2022
Serial Number
79233966
Mark Type
4000
Filing Date
Saturday, March 24, 2018
Abandoned Date
Tuesday, January 4, 2022

Trademark Owner History
NOVARTIS AG - Owner At Publication

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Sep 25, 2022
Notification Processed By Ib
May 30, 2022
Notification Processed By Ib
May 6, 2022
Notification Of Effect Of Cancellation Of Intl Reg Mailed
May 5, 2022
Death Of International Registration
May 5, 2022
Correction From Ib Entered - No Review Required
May 4, 2022
Notification Of Possible Opposition Sent To Ib
May 4, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 4, 2022
Notice Of Publication
Apr 20, 2022
Attorney Review Completed
Apr 18, 2022
Attorney Review/Decision On Amendment Required
Mar 7, 2022
Reg. Cancelled - Restored To Pendency
Feb 28, 2022
Assigned To Petition Staff
Feb 23, 2022
Request To Cancel Inadvertently Issued Registration Received
Dec 28, 2018
Notification Processed By Ib
Dec 20, 2018
Correction Transaction Received From Ib
Dec 2, 2018
Final Disposition Notice Sent To Ib
Dec 2, 2018
Final Disposition Processed
Nov 15, 2018
Grant Of Protection Created, To Be Sent To Ib
Oct 16, 2018
Registered-Principal Register
Jul 31, 2018
Published For Opposition
Jul 11, 2018
Notice Of Publication
Jun 27, 2018
Approved For Pub - Principal Register
Jun 26, 2018
Assigned To Examiner
Jun 16, 2018
Application Filing Receipt Mailed
Jun 12, 2018
New Application Office Supplied Data Entered In Tram
Jun 11, 2018
Limitation From Original Application Entered
Jun 7, 2018
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24